Literature DB >> 21326728

Hilar biliary obstruction: malignant masquerades.

Anne M Covey1, George I Getrajdman.   

Abstract

Biliary obstruction at the hepatic hilus is most often due to malignancy. Clinically, it can be very difficult to differentiate malignant from benign obstruction when a mass lesion is not evident on cross-sectional imaging. In this article, we describe three cases of benign biliary obstruction due to so-called malignant masquerades to familiarize the reader with the clinical, radiographic, and pathological features of these uncommon but important entities.

Entities:  

Keywords:  Biliary obstruction; Clonorchis sinensis; autoimmune pancreatitis; chemotherapy-induced biliary sclerosis

Year:  2007        PMID: 21326728      PMCID: PMC3036343          DOI: 10.1055/s-2007-971179

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  19 in total

1.  A case of autoimmune pancreatitis associated with sclerosing cholangitis, retroperitoneal fibrosis and Sjögren's syndrome.

Authors:  Toshiro Fukui; Kazuichi Okazaki; Hazuki Yoshizawa; Shinya Ohashi; Hiroyuki Tamaki; Kimio Kawasaki; Minoru Matsuura; Masanori Asada; Hiroshi Nakase; Yasuaki Nakashima; Akiyoshi Nishio; Tsutomu Chiba
Journal:  Pancreatology       Date:  2005-03-16       Impact factor: 3.996

2.  Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver.

Authors:  Robert C G Martin; Michael J Edwards; Kelly M McMasters
Journal:  Am J Surg       Date:  2004-12       Impact factor: 2.565

3.  Obstructive jaundice in patients receiving hepatic artery infusional chemotherapy: etiology, treatment implications, and complications after transhepatic biliary drainage.

Authors:  K T Brown; N Kemeny; M F Berger; G I Getrajdman; T Napp; Y Fong; S Herman; R C Kurtz; J Botet; L H Blumgart
Journal:  J Vasc Interv Radiol       Date:  1997 Mar-Apr       Impact factor: 3.464

Review 4.  Diagnostic criteria for autoimmune chronic pancreatitis revisited.

Authors:  Kyu-Pyo Kim; Myung-Hwan Kim; Jong Cheol Kim; Sang Soo Lee; Dong Wan Seo; Sung Koo Lee
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

5.  Multiple hepatic nodules: rare manifestation of clonorchiasis.

Authors:  Wei-Chih Liao; Hsiu-Po Wang; Han-Mo Chiu; Chi-Yang Chang; Jaw-Town Lin
Journal:  J Gastroenterol Hepatol       Date:  2006-09       Impact factor: 4.029

Review 6.  Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis.

Authors:  Byung Ihn Choi; Joon Koo Han; Sung Tae Hong; Kyoung Ho Lee
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 7.  An update on hepatic arterial infusion chemotherapy for colorectal cancer.

Authors:  Adam D Cohen; Nancy E Kemeny
Journal:  Oncologist       Date:  2003

8.  Effects of dexamethasone or celecoxib on biliary toxicity after hepatic arterial infusion of 5-fluorodeoxyuridine in a canine model.

Authors:  William Ensminger; James Knol; Susan DeRemer; Erby Wilkinson; Suzette Walker; David Williams; Jonathan Maybaum
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

9.  Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma.

Authors:  Sharon M Weber; Olcay Cubukcu-Dimopulo; J Alexander Palesty; Arief Suriawinata; David Klimstra; Murray F Brennan; Kevin Conlon
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

10.  A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.

Authors:  N Kemeny; K Seiter; D Niedzwiecki; D Chapman; E Sigurdson; A Cohen; J Botet; P Oderman; P Murray
Journal:  Cancer       Date:  1992-01-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.